Pubblicazioni

Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA-AF registry phase III

2024 - DIABETES, OBESITY AND METABOLISM
Liu, Yang; Chen, Yang; Lam, Steven H M; Huang, Bi; Romiti, Giulio F; Alam, Uazman; Chao, Tze Fan; Olshansky, Brian; Hong, Kui; Huisman, Menno V; Lip, Gregory Y H

Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open-label, crossover, active-comparator FIORE trial

2022 - DIABETES, OBESITY AND METABOLISM
Succurro, Elena; Vizza, Patrizia; Papa, Annalisa; Miceli, Sofia; Cicone, Francesco; Fiorentino, Teresa Vanessa; Sciacqua, Angela; Andreozzi, Francesco; Veltri, Pierangelo; Cascini, Giuseppe Lucio; Sesti, Giorgio

Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice: The case of glucagon-like peptide-1 receptor agonists

2020 - DIABETES, OBESITY AND METABOLISM
Sciannameo, V.; Berchialla, P.; Orsi, E.; Lamacchia, O.; Morano, S.; Querci, F.; Consoli, A.; Avogaro, A.; Fadini, G. P.

Long-term Risk of Cardiovascular Disease in Individuals with Latent Autoimmune Diabetes of Adults (UKPDS 85)

2019 - DIABETES, OBESITY AND METABOLISM
Maddaloni, E; Coleman, R L; Pozzilli, P; Holman, R R

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma